pubmed tirzepatide Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review Tirzepatide on ingestive behavior in

Levine YA, Koopman FA, Faltys M, Caravaca A, Bendele A, Zitnik R, et al

Portion control is key

961964 Persons with DM should be recommended to engage in flexibility and range of motion training, which can have significant impacts on A1C, flexibility, muscle strength, and balance, especially in older adults with DM

Tirzepatide (Mounjaro), a newer dual GIP/GLP-1 receptor agonist, is also available in the UK, though it may also cause gastrointestinal side effects

Unlike oral medications you remember to take with water, GLP-1 injections don't come with the same behavioral cue to hydrate

If the diagnosis is TE, the recommendation will typically be nutrient optimization and patience